MedTrace Logo

Reduction in IV Associated Contamination

NCT01426217 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 594

Last updated 2018-10-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to investigate whether implementing a novel syringe and IV stopcock cap system impregnated with alcohol will reduce IV catheter bacterial contamination and infections in patients.

Conditions

  • Post-operative Infections

Interventions

DEVICE

Passive Bundle PSI (Problem Solving Innovations) Medical HubScrub, PSI Medical DocIt

Implementation of passive bundle which includes HubScrub and DocIt device into the operating room environment.

Sponsors & Collaborators

  • PSI Medical

    collaborator UNKNOWN

  • Dartmouth-Hitchcock Medical Center

    lead OTHER

Principal Investigators

  • Bryan S Brindeiro, MD · Dartmouth-Hitchcock Medical Center

  • Randy W Loftus, MD · Dartmouth-Hitchcock Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2011-11-30
Completion
2011-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01426217 on ClinicalTrials.gov